A Rare Case of Late-Onset Ertapenem-Induced Encephalopathy.
drug-induced encephalopathy
drug-reaction
ertapenem
ertapenem induced encephelopathy
ertapenem side-effect
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
10
08
2023
medline:
19
9
2023
pubmed:
19
9
2023
entrez:
19
9
2023
Statut:
epublish
Résumé
Encephalopathy is a rare side effect associated with carbapenem antibiotics, typically presenting within one week of initiating treatment. It is almost exclusively seen in patients with poor renal function. We present a case of a middle-aged male with a history of cerebral vascular accident and normal renal function admitted for agitation, delirium, and insomnia more than two weeks after starting ertapenem to treat osteomyelitis. He was empirically treated for meningitis on admission, and ertapenem was discontinued. After an extensive negative workup for infectious and neurological etiologies of encephalopathy, a presumptive diagnosis of ertapenem-induced encephalopathy was made. The patient returned to his baseline mental status five days after discontinuing ertapenem. The nature of his neurological symptoms and timely resolution after stopping ertapenem is consistent with ertapenem-induced encephalopathy and represents a notably delayed symptom onset compared to previously described cases.
Identifiants
pubmed: 37724203
doi: 10.7759/cureus.43713
pmc: PMC10505488
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e43713Informations de copyright
Copyright © 2023, Teague et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Daru. 2022 Jun;30(1):159-163
pubmed: 35023080
J Investig Med High Impact Case Rep. 2017 Jan 01;5(1):2324709616689376
pubmed: 28203577
J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii7-9
pubmed: 15150178
PLoS One. 2017 Jul 31;12(7):e0182046
pubmed: 28759588
Int J Clin Pharm. 2018 Aug;40(4):903-910
pubmed: 30051231
Ann Pharmacother. 2011 Jan;45(1):e6
pubmed: 21177419
Drug Saf. 2017 Dec;40(12):1171-1198
pubmed: 28755095
Clin Nephrol. 2013 Dec;80(6):474-8
pubmed: 22579271
BMJ Case Rep. 2020 Jun 1;13(6):
pubmed: 32487528
Infect Drug Resist. 2023 Jun 08;16:3649-3658
pubmed: 37313264
Int J Clin Pharm. 2013 Aug;35(4):535-7
pubmed: 23801127